• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Use of proteasome inhibitors.

作者信息

Downey Sondra L, Florea Bogdan I, Overkleeft Herman S, Kisselev Alexei F

机构信息

Norris Cotton Cancer Center and Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.

Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, Leiden, The Netherlands.

出版信息

Curr Protoc Immunol. 2015 Apr 1;109:9.10.1-9.10.8. doi: 10.1002/0471142735.im0910s109.

DOI:10.1002/0471142735.im0910s109
PMID:25845565
Abstract

Proteasome inhibitors are indispensable research tools in immunology and cell biology. With numerous proteasome inhibitors available commercially, choosing the appropriate compound for a biological experiment may be challenging, especially for a novice. This unit provides an overview of the proteasome inhibitors commonly used in research. It discusses how to select an appropriate highly specific inhibitor, its concentration, and length of exposure for mammalian cell culture experiments. In addition, assays that can be used to confirm proteasome inhibition are discussed.

摘要

相似文献

1
Use of proteasome inhibitors.
Curr Protoc Immunol. 2015 Apr 1;109:9.10.1-9.10.8. doi: 10.1002/0471142735.im0910s109.
2
Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.探究潜在草药药物 Withaferin A 对哺乳动物抗癌机制的研究:以人源和牛源蛋白酶体为例。
BMC Genomics. 2010 Dec 2;11 Suppl 4(Suppl 4):S15. doi: 10.1186/1471-2164-11-S4-S15.
3
The significance of ubiquitin proteasome pathway in cancer development.泛素蛋白酶体通路在癌症发展中的意义。
Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):298-309. doi: 10.2174/1574891x113089990033.
4
[Ubiquitin-proteasome pathway as a target for therapeutic strategies].[泛素-蛋白酶体途径作为治疗策略的靶点]
Postepy Biochem. 2017;63(4):287-303.
5
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors.优化含有 P3 双环支架的肽模拟硼酸酯作为蛋白酶体抑制剂。
Eur J Med Chem. 2014 Aug 18;83:1-14. doi: 10.1016/j.ejmech.2014.06.017. Epub 2014 Jun 10.
6
Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).新型铜配合物作为癌症治疗的潜在蛋白酶体抑制剂(综述)
Mol Med Rep. 2017 Jan;15(1):3-11. doi: 10.3892/mmr.2016.6022. Epub 2016 Dec 9.
7
Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.泛素-蛋白酶体系统及其抑制剂在癌症治疗中的作用。
Open Biol. 2021 Apr;11(4):200390. doi: 10.1098/rsob.200390. Epub 2021 Apr 28.
8
Indomethacin elicits proteasomal dysfunctions develops apoptosis through mitochondrial abnormalities.吲哚美辛引发蛋白酶体功能障碍并通过线粒体异常导致细胞凋亡。
J Cell Physiol. 2018 Feb;233(2):1685-1699. doi: 10.1002/jcp.26081. Epub 2017 Aug 23.
9
Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.阻断泛素-蛋白酶体系统通过加速破骨细胞分化中 M-CSF 受体 c-Fms 的降解来预防炎症诱导的骨丢失。
Int J Mol Sci. 2017 Sep 25;18(10):2054. doi: 10.3390/ijms18102054.
10
Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.表二氢二酮哌嗪类化合物通过靶向蛋白酶体去泛素化酶 Rpn11 抑制蛋白降解。
Cell Chem Biol. 2018 Nov 15;25(11):1350-1358.e9. doi: 10.1016/j.chembiol.2018.07.012. Epub 2018 Aug 23.

引用本文的文献

1
Inhibitors of the ubiquitin proteasome system block myofibril assembly in cardiomyocytes derived from chick embryos and human pluripotent stem cells.泛素蛋白酶体系统抑制剂可阻止鸡胚和人多能干细胞来源的心肌细胞中肌原纤维的组装。
Cytoskeleton (Hoboken). 2021 Oct;78(10-12):461-491. doi: 10.1002/cm.21697. Epub 2022 May 24.
2
The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.von Hippel-Lindau Cullin-RING E3 泛素连接酶调节 APOBEC3 胞嘧啶脱氨酶。
Transl Res. 2021 Nov;237:1-15. doi: 10.1016/j.trsl.2021.05.002. Epub 2021 May 15.
3
Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.
通过两种强效哌啶酮抑制蛋白酶体诱导白血病/淋巴瘤细胞凋亡。
Cell Oncol (Dordr). 2018 Dec;41(6):623-636. doi: 10.1007/s13402-018-0397-1. Epub 2018 Aug 7.
4
Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.卡非佐米相较于硼替佐米对果蝇模型的退行性影响更小:与临床不良事件相关联。
Sci Rep. 2017 Dec 19;7(1):17802. doi: 10.1038/s41598-017-17596-4.
5
Nrf1 can be processed and activated in a proteasome-independent manner.Nrf1可以通过一种不依赖蛋白酶体的方式进行加工和激活。
Curr Biol. 2016 Sep 26;26(18):R834-R835. doi: 10.1016/j.cub.2016.08.008.